Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC supplier. Our longstanding policy of having an anti-markup payment limitation on purchased TCs was codified in §414.50, and retained in the CY 2008 PFS final rule with comment period. (Similarly, we imposed an anti-markup payment limitation on purchased PCs in the CY 2008 PFS final rule with comment period and we proposed in the CY 2009 PFS proposed rule to retain status as a purchased PC as a separate basis imposing an anti-markup payment limitation.) Based on our decision to adopt Alternative 1 and to allow arrangements that do not meet the requirements of Alternative 1 to nevertheless avoid the anti-markup payment limitation if diagnostic testing services meet the requirements of Alternative 2, we believe that it is not necessary, and unduly complex, to use purchased tests and purchased interpretations as separate bases for imposing an anti-markup payment limitation. We provide a fuller explanation below, at section N.2.h., for deleting from §414.50 references to TCs and PCs purchased from an “outside supplier.” We are not creating an exception for tests ordered by a physician in a physician organization with no physician owners who have the right to receive profit distributions. By finalizing both proposed alternatives, we believe that our concern that the Alternative 2 approach could 428

CMS-1403-FC disadvantage nonproblematic arrangements involving nonprofit multi-specialty groups that have campus-based treatment facilities (and thus do not perform diagnostic testing in the same building as where patients are seen) largely becomes moot, as most such arrangements should be able to be structured to fit into Alternative 1, or failing that, Alternative 2. With respect to our specific solicitations of comments, we are not revising the meaning of “net charge” at this time. Moreover, we are not requiring at this time direct billing instead of permitting reassignment under certain circumstances; however, we may propose to do so in a future notice of proposed rulemaking. We considered the various recommendations commenters offered for the effective date for our revisions. We have decided to not deviate from the effective date that is generally applicable to this final rule with comment period and, thus, the revisions to §414.50 will become effective on January 1, 2009. Finally, we did not propose to make changes to the in- office ancillary services exception and are not making any changes to that exception in this final rule; however, we are aware of the commenters’ concerns and may propose rulemaking on this issue in the future. 429

<strong>CMS</strong>-1403-FC<br />

supplier. Our longstanding policy of having an anti-markup<br />

payment limitation on purc<strong>has</strong>ed TCs was codified in<br />

§414.50, and retained in the CY 2008 PFS final rule with<br />

comment period. (Similarly, we imposed an anti-markup<br />

payment limitation on purc<strong>has</strong>ed PCs in the CY 2008 PFS<br />

final rule with comment period and we proposed in the CY<br />

2009 PFS proposed rule to retain status as a purc<strong>has</strong>ed PC<br />

as a separate basis imposing an anti-markup payment<br />

limitation.) Based on our decision to adopt Alternative 1<br />

and to allow arrangements that do not meet the requirements<br />

of Alternative 1 to nevertheless avoid the anti-markup<br />

payment limitation if diagnostic testing services meet the<br />

requirements of Alternative 2, we believe that it is not<br />

necessary, and unduly complex, to use purc<strong>has</strong>ed tests and<br />

purc<strong>has</strong>ed interpretations as separate bases for imposing an<br />

anti-markup payment limitation. We provide a fuller<br />

explanation below, at section N.2.h., for deleting from<br />

§414.50 references to TCs and PCs purc<strong>has</strong>ed from an<br />

“outside supplier.”<br />

We are not creating an exception for tests ordered by<br />

a physician in a physician organization with no physician<br />

owners who have the right to receive profit distributions.<br />

By finalizing both proposed alternatives, we believe that<br />

our concern that the Alternative 2 approach could<br />

428

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!